Business

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care NEW YORK

articleWaldencast PlcJanuary 30, 20265/company/waldencast-acquisition-corp/news/obagi-medical-and-vio-med-spa-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

About this update from Waldencast Plc

[{"type":"text","content":"VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care\nNEW YORK and STRONGSVILLE, Ohio, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced VIO Med Spa as a launch partner for the Aesthetics Leadership with Obagi’s Hyaluronic Acid (ALOHA) Program. VIO Med Spa was selected for its rapid growth, expert-led approach to advanced aesthetic treatments, and dedication to delivering high-quality, results-driven care across its expanding national network of locations. Through this real-world evaluation collaboration, VIO Med Spa will conduct a structured, multi-site assessment of Obagi® saypha® MagIQ™ across its practices. The program will leverage VIO Med Spa’s strengths in innovative injectables, personalized wellness protocols, and patient-focused education to generate robust real-world evidence on the filler’s performance in diverse, high-volume aesthetic environments. “At VIO Med Spa, we’re committed to elevating aesthetic medicine through clinical excellence, innovation, and exceptional patient outcomes,” said Dr. Alan Durkin, Chief Medical Officer of VIO Med Spa. “Obagi’s ALOHA Program perfectly aligns with our mission by emphasizing real-world data and integrated skincare-injectable protocols. This partnership allows us to contribute meaningful insights that enhance results for our patients and advance the industry as a whole.” The ALOHA Program evaluates both clinical performance and patient experience while providing providers with comprehensive Obagi protocols to boost satisfaction, build lasting relationships, and achieve consistent, high-quality outcomes. Standardized data will be collected across participating VIO Med Spa locations. The program kicks off at the upcoming VIO University program which includes 2 days of immersive expert led training for the VIO network of practices. “Partnering with a dynamic, growth-oriented leader like VIO Med Spa reinforces Obagi’s commitment to launching aesthetics solutions grounded in authentic, practice-based evidence,” said Drew Fine, U.S. General Manager, Professional Channel. “The ALOHA collaboration with VIO Med Spa brings toge...

More updates from Waldencast Plc